doi: 10.3389/fimmu.2025.1610368 Received 11 April 2025 Accepted 26 June 2025 Published 15 July 2025 Volume 16 - 2025 Edited by Li-Tung Huang, Kaohsiung Chang Gung Memorial Hospital, Taiwan Reviewed by Beata Kasztelan-Szczerbinska, Medical University of Lublin, Poland Edit Posta, University of Debrecen, Hungary Updates Copyright 2025 Migliorisi, Gabbiadini, Dal Buono, Ferraris, Privitera, Petronio, Bertoli, Bezzio and Armuzzi
A.van GoorH.HillebrandsJ
When Contrave May Be the Right Choice Despite its lower efficacy, Contrave may be appropriate in specific clinical scenarios: Needle phobia: Contrave is an oral medication
For anyone weighing convenience against comprehensive care, mobile IV therapy bridges that gap
GHK-Cu has been studied for its role in supporting hair follicle health, prolonging the hair growth phase, and improving scalp condition
Discontinuation analyses reveal concerning rebound patterns with participants regaining substantial weight after stopping medication